Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
News search results
19 Results for ''
Translation News
Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
October 2, 2024
Press Release
DNA origami-based vaccines toward safe and highly-effective precision cancer immunotherapy
March 15, 2024
Research Spotlights
Ultrasensitive Blood Test Detects ‘Pan-Cancer’ Biomarker
October 6, 2023
Press Release
CAR-T cell cancer immunotherapy gets personal
February 10, 2023
Press Release
Enhanced cancer immunotherapies through cytokine-labeled T cells
January 10, 2023
Press Release
DNA nanostructures grow up to become micron-scale megastructures
December 21, 2022
Awards
Elizabeth Carstens and Yang Claire Zeng selected as 3rd recipients of Harvard’s “Immuno-engineering to Improve Immunotherapy” (i3) Center award
December 14, 2022
Press Release
Deconstructing the mechanics of bone marrow disease
July 11, 2022
Research Spotlights
New cancer vaccine delivers double punch to tumors
May 27, 2022
Research Spotlights
“Immuno-engineering to Improve Immunotherapy” (i3) Center at Harvard University selects Dana-Farber cancer-immunologist Rizwan Romee as its 2021 grant recipient
December 13, 2021
Press Release
Planting the seed for DNA nanoconstructs that grow to the micron scale
March 23, 2021
Research Spotlights
Harvard “Immuno-engineering to Improve Immunotherapy” (i3) Center at the Wyss Institute awards first grant to Dana-Farber cancer immunologist Eric Smith
January 21, 2021
Research Spotlights
i3 Center: Biomaterials to Create T Cell Immunity
July 1, 2020
Awards
Harvard’s Wyss Institute announces cross-institutional “Immuno-engineering to Improve Immunotherapy (
i3
)” Center to advance cancer therapy
March 6, 2020
Research Spotlights
Harnessing Nature to Beat Cancer
February 28, 2019
Press Release
Predicting leaky heart valves with 3D printing
December 10, 2018
Translation News
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
March 20, 2018
Press Release
Inciting an immune attack on cancer cells
August 25, 2015
Translation News
Cross-disciplinary team from Harvard University and Dana-Farber Cancer Institute brings novel therapeutic cancer vaccine to human clinical trials
September 6, 2013
Close search results
close menu
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu
